Variable | Study population (n = 65) | p53-MCL positive (n = 5) |
---|---|---|
Age-years | ||
 Average | 50.4 | 44.4 |
 Range | 30–82 | 32–51 |
Age onset tumor appearance | ||
 Average | 42.5 | 38.6 |
 Range | 24–67 | 28–43 |
Diagnosis | ||
 Ductal | 47 (72.3 %) | 3 (60 %) |
 Lobular | 8 (12.3 %) | 0 |
 Unknown | 8 (12.3 %) | 2 (40 %) |
 Other | 2 (3.1 %) | 0 |
ER status | ||
 Negative | 15 (23.1 %) | 0 |
 Positive | 36 (55.4 %) | 5 (100 %) |
 Unknown | 14 (21.5 %) | 0 |
PgR status | ||
 Negative | 19 (29.2 %) | 0 |
 Positive | 32 (49.2 %) | 5 (100 %) |
 Unknown | 14 (21.5 %) | 0 |
HER2 status | ||
 Negative | 29 (44.6 %) | 4 (80 %) |
 Positive | 16 (24.6 %) | 1 (20 %) |
 Unknown | 20 (30.8 %) | 0 |
BRCAPRO | 32.3 | 52.2 |